MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a.
暂无分享,去创建一个
Derek Y. Chiang | T. Golub | V. Mazzaferro | S. Friedman | J. Bruix | J. Llovet | Clara Alsinet | S. Waxman | Y. Hoshida | S. Thung | A. Villanueva | M. Schwartz | S. Roayaie | B. Mínguez | V. Tovar | S. Toffanin | A. Lachenmayer | R. Savić | S. Ward | L. Cabellos
[1] Derek Y. Chiang,et al. IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage. , 2010, Journal of hepatology.
[2] Ming Yao,et al. Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA , 2010, Nature Cell Biology.
[3] Jörn Bullerdiek,et al. The Two Stem Cell MicroRNA Gene Clusters C19MC and miR-371-3 Are Activated by Specific Chromosomal Rearrangements in a Subgroup of Thyroid Adenomas , 2010, PloS one.
[4] J. Llovet,et al. miRNA delivery: emerging therapy for hepatocellular carcinoma. , 2010, Gastroenterology.
[5] J. Llovet,et al. Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. , 2010, Seminars in liver disease.
[6] S. Lowe,et al. miR-221 overexpression contributes to liver tumorigenesis , 2009, Proceedings of the National Academy of Sciences.
[7] V. P. Collins,et al. Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. , 2009, Cancer cell.
[8] Thomas E. Royce,et al. Whole-Genome Gene Expression Profiling of Formalin-Fixed, Paraffin-Embedded Tissue Samples , 2009, PloS one.
[9] K. Tsai,et al. Epigenetic control of the expression of a primate-specific microRNA cluster in human cancer cells , 2009, Epigenetics.
[10] J. Yun,et al. Effects of MicroRNA‐29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma , 2009, Hepatology.
[11] Stephanie Roessler,et al. MicroRNA expression, survival, and response to interferon in liver cancer. , 2009, The New England journal of medicine.
[12] S. Thorgeirsson,et al. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties , 2009, Oncogene.
[13] T. Takizawa,et al. Human Villous Trophoblasts Express and Secrete Placenta-Specific MicroRNAs into Maternal Circulation via Exosomes1 , 2009, Biology of reproduction.
[14] Derek Y. Chiang,et al. Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo. , 2009, Journal of hepatology.
[15] Derek Y. Chiang,et al. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. , 2009, Cancer research.
[16] A. Jemal,et al. Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.
[17] Kathryn A. O’Donnell,et al. Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model , 2009, Cell.
[18] Ping Jin,et al. MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells , 2009, Journal of Translational Medicine.
[19] S. Paggi,et al. Sorafenib in Advanced Hepatocellular Carcinoma , 2008 .
[20] Derek Y. Chiang,et al. Pivotal role of mTOR signaling in hepatocellular carcinoma. , 2008, Gastroenterology.
[21] Kenji Ikeda,et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. , 2008, The New England journal of medicine.
[22] W. L. Ruzzo,et al. MicroRNA Discovery and Profiling in Human Embryonic Stem Cells by Deep Sequencing of Small RNA Libraries , 2008, Stem cells.
[23] Derek Y. Chiang,et al. Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. , 2008, Cancer research.
[24] Ron Shamir,et al. Comprehensive MicroRNA Profiling Reveals a Unique Human Embryonic Stem Cell Signature Dominated by a Single Seed Sequence , 2008, Stem cells.
[25] Laura Pelletier,et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations , 2008, Hepatology.
[26] Artemis G. Hatzigeorgiou,et al. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer , 2008, Proceedings of the National Academy of Sciences.
[27] Sean McWilliam,et al. Origin, evolution, and biological role of miRNA cluster in DLK-DIO3 genomic region in placental mammals. , 2008, Molecular biology and evolution.
[28] R. Aharonov,et al. MicroRNAs accurately identify cancer tissue origin , 2008, Nature Biotechnology.
[29] Jin Woo Kim,et al. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. , 2008, Cancer research.
[30] L. Lang. FDA approves sorafenib for patients with inoperable liver cancer. , 2008, Gastroenterology.
[31] Lin Zhang,et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis , 2008, Nature Cell Biology.
[32] T. Golub,et al. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia , 2007, Proceedings of the National Academy of Sciences.
[33] Jill P. Mesirov,et al. Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets , 2007, PloS one.
[34] J. Zucman‐Rossi,et al. Genetic diversity of hepatocellular carcinomas and its potential impact on targeted therapies. , 2007, Pharmacogenomics.
[35] K. Ghoshal,et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. , 2007, Gastroenterology.
[36] H. El‐Serag,et al. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.
[37] Derek Y. Chiang,et al. Genomics and signaling pathways in hepatocellular carcinoma. , 2007, Seminars in liver disease.
[38] George P Cobb,et al. microRNAs as oncogenes and tumor suppressors. , 2007, Developmental biology.
[39] S. Boyault,et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets , 2007, Hepatology.
[40] V. Mazzaferro,et al. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. , 2006, Gastroenterology.
[41] S. Thorgeirsson,et al. Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. , 2006, The Journal of clinical investigation.
[42] J. Mesirov,et al. GenePattern 2.0 , 2006, Nature Genetics.
[43] T. Okanoue,et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues , 2006, Oncogene.
[44] R. DePinho,et al. Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[45] Chang-Zheng Chen,et al. MicroRNAs as oncogenes and tumor suppressors. , 2005, The New England journal of medicine.
[46] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[47] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[48] S. Thorgeirsson,et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling , 2004, Hepatology.
[49] Jian-Bing Fan,et al. A versatile assay for high-throughput gene expression profiling on universal array matrices. , 2004, Genome research.
[50] C. Croce,et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[51] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[52] C. Burge,et al. Prediction of Mammalian MicroRNA Targets , 2003, Cell.
[53] Pierre Baldi,et al. A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes , 2001, Bioinform..
[54] S. Schmid,et al. Regulation of macropinocytosis by p21-activated kinase-1. , 2000, Molecular biology of the cell.
[55] Kadhim,et al. Inhibition of tumor growth with doxorubicin in a new orthotopically implanted human hepatocellular carcinoma model. , 2000, Hepatology research : the official journal of the Japan Society of Hepatology.
[56] T. Yamane,et al. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. , 1982, Cancer research.
[57] Wei Wu,et al. MicroRNA-Based Therapeutics for Cancer , 2012, BioDrugs.
[58] R. Weinberg,et al. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2008, Nature.
[59] R. Aharonov,et al. Identification of hundreds of conserved and nonconserved human microRNAs , 2005, Nature Genetics.
[60] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[61] D. Woodfield. Hepatocellular carcinoma. , 1986, The New Zealand medical journal.